Brokerages forecast that Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating) will report sales of $2.90 million for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates for Rhythm Pharmaceuticals’ earnings, with the highest sales estimate coming in at $3.50 million and the lowest estimate coming in at $2.30 million. Rhythm Pharmaceuticals reported […]
Equities research analysts expect Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating) to post sales of $2.90 million for the current fiscal quarter, according to Zacks. Two analysts have made estimates for Rhythm Pharmaceuticals’ earnings, with the lowest sales estimate coming in at $2.30 million and the highest estimate coming in at $3.50 million. Rhythm Pharmaceuticals […]
Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating) have been given a consensus recommendation of “Hold” by the ten research firms that are covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, two have issued a hold recommendation and five have given a buy recommendation to […]
Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Rating) had its price target reduced by stock analysts at The Goldman Sachs Group from $8.00 to $7.00 in a research note issued to investors on Tuesday, Stock Target Advisor reports. The brokerage presently has a “neutral” rating on the stock. The Goldman Sachs Group’s price target would indicate a […]
Wall Street analysts forecast that Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating) will report sales of $2.45 million for the current quarter, Zacks reports. Two analysts have made estimates for Rhythm Pharmaceuticals’ earnings, with estimates ranging from $2.40 million to $2.50 million. Rhythm Pharmaceuticals posted sales of $40,000.00 during the same quarter last year, which […]